Trial intelligence / Profile preview

Cat-PAD in cat allergy

NCT00729508Phase 2Completed

Sponsor
NIOX Group
Start
Aug 2008
Primary completion
Apr 2009
Modality
Peptides
Countries
1
01

Overview

A Phase 2 trial of Cat-PAD in cat allergy, sponsored by NIOX Group. Started Aug 2008; status: completed.

02

Drugs

Cat-PAD
03

Conditions

cat allergy

Beyond the preview

Go deeper on NCT00729508.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00729508.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call